-
New medicine for rare diseases! Fda approved Ravicti (benzoate glyceride) for urea circulation disorders under 2 months:
Time of Update: 2021-02-16
Recently, the company announced that the U.S. Food and Drug Administration (FDA) has approved the expansion of oral fluids from Gavicti (glycerol phenylbutyrate) to include infants under 2 months of age with urea circulation disorder (UCD).
-
Communications Biology: Vision tests can predict cognitive decline associated with Parkinson's disease 18 months in advance
Time of Update: 2021-01-26
new study, published recently in the journal Biology, the same team found that the structural and functional connections in various regions of the brain in people with Parkinson's disease become separated throughout the brain, especially those with vision problems.
-
Treatment of six months of aggravation of the disease "tongue cancer" misdiagnosed as "mouth sores" patients claim 440,000!
Time of Update: 2021-01-18
the failure to pay attention to the obligations, negligence and other medical disputes leading to legal risks. (this article is original medical law, based on the real case adaptation, in order to protect the privacy of the parties are using a real name)
-
Sanofi vaccine is approved by the European Union for the prevention of meningococcal disease in people 12 months and older
Time of Update: 2021-01-17
On November 23rd, the European Commission (EC) approved the Sanofi-Pasteur vaccine MenQuadfi® to actively immunized against invasive meningococcal disease caused by meninges A, C, W and Y.
-
Sanofi vaccine is approved by the European Union for the prevention of meningococcal disease in people 12 months and older
Time of Update: 2021-01-07
On 23 November, the European Commission (EC) approved the Sanofi-Pasteur vaccine MenQuadfi® to be actively immunized against invasive meningococcal disease caused by Meningitis A, C, W and Y.
-
JNNP: Risk Score for Middle-aged and Alzheimer's Disease and Ageing Awareness: A Population-Based Twin Study That Followed For More Than 20 Years
Time of Update: 2020-11-27
conclusion: Middle-aged dementia risk scores predict cognitive function in older adults, but correlations within the twin group rarely support associations independent of common environments and genetic factors.
-
The Chinese Nutrition Society co-sponsored the National Healthy Lifestyle Awareness Month series of activities.
Time of Update: 2020-10-19
In order to implement the requirements of the Healthy China Initiative (2019-2030) and the National Healthy Lifestyle Action Plan (2017-2025), we will further promote the National Healthy Lifestyle Initiative on the theme of "Three Minus Three
-
Refresh your awareness! It turns out that Parkinson's disease is not a disease, but two.
Time of Update: 2020-10-16
XY diagram shows that the brain-first and body-first Parkinson's disease map (A) describes the FDOPA specific binding ratio (SBR) value on the x-axis and the late image 123I-MIBG H/M ratio on the y-axis.
-
Brain: Refresh your awareness! It turns out that Parkinson's disease is not a disease, but two.
Time of Update: 2020-10-05
XY diagram shows that the brain-first and body-first Parkinson's disease map (A) describes the FDOPA specific binding ratio (SBR) value on the x-axis and the late image 123I-MIBG H/M ratio on the y-axis.
-
Clin Gastroenterology H: Normalization of fecal calcitonin within 12 months of diagnosis
Time of Update: 2020-08-30
long-term follow-up of fecal calcitonin levels within one year of diagnosis in patients with Crohn's disease found that the normalization of fecal calcitonin was associated with a good prognosis of the disease.
-
Dig Liver Dis: Changes in fecal calcitonin levels in the first three months after a intestinal
Time of Update: 2020-08-29
study was conducted to assess the relationship between continuous fecal calcitonin (Fcal) levels and recurrence under the CD endoscopy in the first three months after surgery.
-
Clin Exp Rheumatol: Surfactive protein D associated with 3-month mortality from anti-MDA5 antibody-interstitial lung disease
Time of Update: 2020-05-29
Multi-factor analysis showed that age (p-0.001, HR 1.151, 95% CI 1.063-1.247) and elevated SPD levels (?75.90 ng/ml, p-0.005, HR 16.411, 95% CI 2.369-113.711) were important predictable indicators of Mortality for Patients with MAD5-IL.
-
National Iodine Deficiency Awareness Day: Prevention of ketin disease, which is important for "iodine"
Time of Update: 2020-05-18
Iodine deficiency leads to maternal hypothyroidism (early pregnancy) or insufficient fetal thyroid hormone secretion (third trimester) may affect fetal growth and development, due to cretinism.
-
Boosting awareness of polysaccharide disease, first patient survival report officially released
Time of Update: 2020-05-15
Guide: A number of senior associations to participate in the "International Polysaccharide Memory Care Day" officially began. According to the medical intelligence network was informed that on May 15, 2020, "International Sticky
-
Breakthrough drug of chronic graft-versus-host disease (cGVHD)! The total remission rate (ORR
Time of Update: 2020-02-24
February 24, 2020 / BIOON / -- the annual ASBMT / CIBMTR transplantation and Cell Therapy Conference (TCT 2020) was held in Orlando, Florida, USA from February 19 to 23, 2020
-
Cancer individualized vaccine! Tlpldc has a strong therapeutic effect on stage IV melanoma, with a disease-free survival rate of 73% in 24 months!
Time of Update: 2020-02-08
February 8, 2020 / BIOON / -- Elios therapeutics is a biopharmaceutical company dedicated to developing innovative individual therapeutic cancer vaccine
Recently
-
Wang Ping, State Drug Administration: the review of drugs for rare diseases should be completed within 3 months
Time of Update: 2019-03-23
On March 23, the economic summit of "China Development Forum 2019" hosted by the development research center of the State Council was held in Beijing
Wang Ping, director
-
The State Council will reduce the burden on more than 20 million patients by 3% VAT on the first 21 drugs with rare diseases from next month
Time of Update: 2019-02-12
Li Keqiang presided over the executive meeting of the State Council, listened to the report on the handling of proposals proposed by the national two sessions in 2018, promoted
-
Act001, a new glioma drug from Nankai University, has been recognized as a rare disease drug by FDA. The domestic clinical trial is expected to start next month
Time of Update: 2017-11-24
Source: on November 20, 2017-11-24, drug era, after nearly nine years of research and development by Professor Chen Yue's team of Nankai University, the anti glioma stem cell drug
-
Taking high dose vitamin D every month does not prevent cardiovascular disease
Time of Update: 2017-04-07
A study published in a new issue of the Journal of the American Medical Association cardiology recently said that taking high doses of vitamin D every month does not prevent cardiovascular disease.
